Cognitive impact of COVID-19: looking beyond the short term

S Miners, PG Kehoe, S Love - Alzheimer's research & therapy, 2020 - Springer
COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …

COVID-19: characteristics and therapeutics

R Chilamakuri, S Agarwal - Cells, 2021 - mdpi.com
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …

Process mining for healthcare: Characteristics and challenges

J Munoz-Gama, N Martin, C Fernandez-Llatas… - Journal of Biomedical …, 2022 - Elsevier
Process mining techniques can be used to analyse business processes using the data
logged during their execution. These techniques are leveraged in a wide range of domains …

SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation

K Keyhanian, RP Umeton, B Mohit, V Davoudi… - Journal of …, 2021 - Elsevier
Since the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a growing body of evidence indicates …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19

AS Lokhande, PV Devarajan - European Journal of Pharmacology, 2021 - Elsevier
The global pandemic of Coronavirus Disease 2019 (COVID-19) has brought the world to a
grinding halt. A major cause of concern is the respiratory distress associated mortality …

The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review

S Paul, LAB Vázquez, PR Reyes-Pérez… - Virus Research, 2022 - Elsevier
Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-
19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection

P Khare, U Sahu, SC Pandey, M Samant - Virus research, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) recently caused a
pandemic outbreak called coronavirus disease 2019 (COVID-19). This disease has initially …

Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV‐2

A Gour, D Manhas, S Bag, B Gorain… - Phytotherapy …, 2021 - Wiley Online Library
Emergence of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection,
COVID‐19, has become the global panic since December 2019, which urges the global …

COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review

YA Attia, MT El-Saadony, AA Swelum… - … Science and Pollution …, 2021 - Springer
Diseases negatively impact the environment, causing many health risks and the spread of
pollution and hazards. A novel coronavirus, severe acute respiratory syndrome coronavirus …